Leadership Secured: Camlin Fine Sciences Extends Tenure for Key Independent Director

In a move signaling robust corporate governance and continuity, specialty chemicals powerhouse Camlin Fine Sciences (CFS) has announced the proposed re-appointment of Mr. Joseph Conrad D'Souza as an Independent Director. This strategic decision, greenlit by the company's Board of Directors, underscores CFS's commitment to strong leadership and sustained strategic direction.

The Board, at its recent meeting, gave the nod for Mr.

D'Souza's second five-year term, slated to commence from October 1, 2024. This re-appointment, however, remains subject to the crucial approval of the company's shareholders, ensuring transparency and democratic process in its leadership decisions.

Mr. Joseph Conrad D'Souza brings a wealth of experience and invaluable insights to the Camlin Fine Sciences board.

His tenure has been marked by significant contributions, particularly within the Audit Committee, where he currently serves as a vital member. His continued presence is expected to further strengthen the company's financial oversight and ethical frameworks.

Adding to the wave of leadership continuity, the Board also approved the re-appointment of Mr.

Bhushan Nemlekar as a Whole-time Director. This dual emphasis on retaining key talent highlights Camlin Fine Sciences' dedication to maintaining a stable and experienced leadership team as it navigates the dynamic landscape of the specialty chemicals industry.

These re-appointments reflect a proactive approach by Camlin Fine Sciences to solidify its leadership structure, ensuring seasoned guidance for future growth and operational excellence.

The company looks forward to leveraging the continued expertise of both Mr. D'Souza and Mr. Nemlekar as it pursues its ambitious objectives.